Poor management; poor marketing; poor access and coverage on local and national formularies. Trying to get out but it isn't easy

Opioids! enuf said. Endo abandoned the market and we got the drug back-high expectations and we will be competing with generic Suboxone shortly. Don't think corporate has a clue-just look at the opioid market and how it has declined in the last 3 yrs alone

Micromanagement; metrics both unrealistic and arbitrary; lousy management; no teamwork; terrible bonus

Lack of security, unattainable sales goals, lack of bonus due to goals, executive mgmt is clueless, constant turnover at all levels, small pharma w Big Pharma mentality = Dissatisfaction